Theodore J. Criares

Array ( [id] => 3998199 [patent_doc_number] => 05922761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods for in vivo reduction of iron levels and compositions useful therefor' [patent_app_type] => 1 [patent_app_number] => 8/708552 [patent_app_country] => US [patent_app_date] => 1996-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6806 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922761.pdf [firstpage_image] =>[orig_patent_app_number] => 708552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688630 [patent_doc_number] => 05696141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Isoxazoline compounds as 5-lipoxygenase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/700432 [patent_app_country] => US [patent_app_date] => 1996-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2990 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696141.pdf [firstpage_image] =>[orig_patent_app_number] => 700432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043922 [patent_doc_number] => 05874444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Poly (ADP-ribose) polymerase inhibitors to treat diseases associated with cellular senescence' [patent_app_type] => 1 [patent_app_number] => 8/703855 [patent_app_country] => US [patent_app_date] => 1996-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4430 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874444.pdf [firstpage_image] =>[orig_patent_app_number] => 703855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3852315 [patent_doc_number] => 05705197 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Extraction process for producing PLGA microspheres' [patent_app_type] => 1 [patent_app_number] => 8/698896 [patent_app_country] => US [patent_app_date] => 1996-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 3740 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705197.pdf [firstpage_image] =>[orig_patent_app_number] => 698896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3886485 [patent_doc_number] => 05723451 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Nitric oxide synthase (NOS) inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/694998 [patent_app_country] => US [patent_app_date] => 1996-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2941 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723451.pdf [firstpage_image] =>[orig_patent_app_number] => 694998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3793632 [patent_doc_number] => 05780481 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Method for inhibiting activation of the human A3 adenosine receptor to treat asthma' [patent_app_type] => 1 [patent_app_number] => 8/694061 [patent_app_country] => US [patent_app_date] => 1996-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7615 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 240 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780481.pdf [firstpage_image] =>[orig_patent_app_number] => 694061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235260 [patent_doc_number] => 06117895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Pharmaceutical preparations for TNF inhibition' [patent_app_type] => 1 [patent_app_number] => 8/683467 [patent_app_country] => US [patent_app_date] => 1996-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1851 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117895.pdf [firstpage_image] =>[orig_patent_app_number] => 683467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771229 [patent_doc_number] => 05849782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Methods of inhibiting neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 8/679313 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 7556 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849782.pdf [firstpage_image] =>[orig_patent_app_number] => 679313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3895688 [patent_doc_number] => 05750512 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration' [patent_app_type] => 1 [patent_app_number] => 8/673407 [patent_app_country] => US [patent_app_date] => 1996-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4336 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750512.pdf [firstpage_image] =>[orig_patent_app_number] => 673407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3906697 [patent_doc_number] => 05898037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Formulations of magnesium compounds for local application and methods of treatment using the same' [patent_app_type] => 1 [patent_app_number] => 8/678151 [patent_app_country] => US [patent_app_date] => 1996-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7090 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898037.pdf [firstpage_image] =>[orig_patent_app_number] => 678151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008489 [patent_doc_number] => 05888991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Use of phosphorus derivatives of alkaloids for treating endocrinopathies' [patent_app_type] => 1 [patent_app_number] => 8/669409 [patent_app_country] => US [patent_app_date] => 1996-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2086 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 419 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888991.pdf [firstpage_image] =>[orig_patent_app_number] => 669409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934519 [patent_doc_number] => 05939460 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Method of inhibiting NADPH oxidase' [patent_app_type] => 1 [patent_app_number] => 8/676822 [patent_app_country] => US [patent_app_date] => 1996-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10887 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939460.pdf [firstpage_image] =>[orig_patent_app_number] => 676822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038161 [patent_doc_number] => 05856446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Method of treating rheumatoid arthritis with low dose type II collagen' [patent_app_type] => 1 [patent_app_number] => 8/675886 [patent_app_country] => US [patent_app_date] => 1996-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5757 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856446.pdf [firstpage_image] =>[orig_patent_app_number] => 675886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883046 [patent_doc_number] => 05798375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Treatment of arteriosclerosis and xanthoma' [patent_app_type] => 1 [patent_app_number] => 8/676090 [patent_app_country] => US [patent_app_date] => 1996-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10764 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798375.pdf [firstpage_image] =>[orig_patent_app_number] => 676090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702965 [patent_doc_number] => 05674893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/670919 [patent_app_country] => US [patent_app_date] => 1996-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6681 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674893.pdf [firstpage_image] =>[orig_patent_app_number] => 670919 [rel_patent_id] =>[rel_patent_doc_number] =>)